Lu Xiangyi’s refrigerated centrifuge helps pharmaceutical companies preserve data authenticity.

Release time:

2018-11-29


Overview:

Lu Xiangyi’s DL-8M ultra-large-capacity refrigerated centrifuge perfectly meets pharmaceutical companies’ need to preserve authentic data and will facilitate GMP compliance and FDA inspections, thereby promoting the better development of the pharmaceutical industry.

  As 2018 draws to a close, major pharmaceutical companies are entering the final sprint phase, and production tasks have become increasingly busy. Against this backdrop, pharmaceutical manufacturers’ demand for related pharmaceutical equipment has become even more urgent. Recently, a pharmaceutical factory successfully received and put into regular use a batch of DL-8M ultra-large-capacity refrigerated centrifuges purchased from Luxiangyi.

 Image 1.png

  Lu Xiangyi DL-8M Ultra-Large-Capacity Refrigerated Centrifuge

    Image 2.png

  Pharmaceutical factory staff are operating the equipment.

   Lu Xiangyi’s centrifuge can preserve data authenticity.

  The DL-8M ultra-large-capacity refrigerated centrifuge offers powerful functionality, enabling real-time printing of all data. It not only supports three-level password management but also ensures that critical data cannot be altered. This makes it capable of providing all authentic, real-time operational records required for GMP compliance and FDA inspections.

  As is well known, data integrity has long been a key concern in the pharmaceutical industry, both domestically and internationally, and it plays a crucial role throughout the entire lifecycle of a drug. Driven by new domestic policies, inspections in the pharmaceutical sector are becoming increasingly stringent. Moreover, with the exposure of several instances of data falsification by pharmaceutical companies and the CFDA’s formal accession to ICH and integration into the international drug regulatory system, domestic requirements for data integrity will continue to be heightened.

  Against this backdrop, pharmaceutical companies are placing greater emphasis on data integrity. Lu Xiangyi’s DL-8M ultra-large-capacity refrigerated centrifuge perfectly meets pharmaceutical companies’ need to preserve authentic data and will facilitate smoother GMP compliance and FDA inspections, thereby contributing to the better development of the pharmaceutical industry.

 Image 3.png

  Lu Xiangyi’s centrifuge can preserve data authenticity.

   The device boasts numerous functions and has been certified by the U.S. FDA.

  In addition to its feature of preserving data integrity, the DL-8M ultra-large-capacity refrigerated centrifuge boasts numerous other advantages.

  In terms of capacity, the DL-8M ultra-large-capacity refrigerated centrifuge features a storage capacity of over a thousand programs and is equipped with a true-color, extra-large touch LCD screen, enabling functions such as stepwise centrifugation.

  In terms of convenience, the device offers a choice between a large-screen LCD display and a digital display, featuring a user-friendly interface that enables real-time conversion and setting between rpm and RCF. It comes equipped with 10 pre-programmed ramp-up and ramp-down curves, allowing users to set the desired ramp-up and ramp-down times according to their specific needs. The operation is simple and convenient. Additionally, this equipment can be configured with water-cooling for refrigeration upon customer request, and the compressor unit can also be relocated outside the window as per customer requirements, thereby reducing the heat generated by the condenser in the room and minimizing noise levels caused by excessive machinery and compressor operation.

  In terms of automation, the system features a touch panel and programmable operation. The host’s operating parameters can be set according to requirements and are automatically stored. The product is microcomputer-controlled and driven by a high-torque AC variable-frequency motor, ensuring stable operation, low noise, and high speed accuracy.

  In addition, it also boasts advantages such as energy efficiency and environmental protection. Specifically: It uses imported high-performance compressor units and a fluorine-free refrigerant, R404a, which meets environmental standards and delivers excellent cooling performance.

  Currently, this centrifuge has a maximum capacity of 2400 ml × 6, allowing a single batch sample processing volume of up to 14,400 ml. This equipment features an all-in-one sealing ring made of food-grade silicone rubber and complies with GMP certification; it has also obtained U.S. FDA approval.

 Image 4.png

  The Luxiangyi DL-8M ultra-large-capacity refrigerated centrifuge has been put into regular use at the pharmaceutical factory.

   In the future, it will help streamline the production process of thymosin alpha-1 solution.

  Currently, the DL-8M ultra-large-capacity refrigerated centrifuge is being used in the production process for separating thymosin solution.

  According to publicly available information, thymosin—also known as thymopeptide—is a group of physiologically active polypeptides secreted by the thymus tissue. The thymosin commonly used in clinical practice is a small-molecule polypeptide isolated and purified from calf thymus, which exhibits nonspecific immune effects. The thymus contains various hormones classified into three categories—alpha, beta, and gamma—that collectively promote the maturation and differentiation of T cells. Thymosin has been clinically applied in China for over 20 years. In the past, due to inconsistent preparation methods and quality control standards across different formulations, as well as irregular clinical observations, its therapeutic efficacy was difficult to confirm.

  The DL-8M high-capacity refrigerated centrifuge developed by Lu Xiangyi in this batch will effectively enhance the quality and efficacy of thymosin, bringing good news for the adjuvant treatment of various primary or secondary T-cell deficiency diseases, certain autoimmune disorders, conditions characterized by impaired cellular immune function, and tumors. For example, it is particularly beneficial for patients suffering from various types of severe hepatitis, chronic active hepatitis, chronic persistent hepatitis, and cirrhosis. Lu Xiangyi welcomes customers with both personalized and general needs to contact us for inquiries and orders. Centrifuge !